ENDO

News media registration opens for ENDO 09 in Washington, D.C.

Chevy Chase, MD The Endocrine Society's 91st Annual Meeting, ENDO 09 will be held at the Walter E Washington Convention Center in Washington, DC, June 10-13, 2009. Approximately 7,500 scientists and clinicians from all over the world are expected to assemble for this premier meeting of hormone res...

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

Company to Host Conference Call January 6, 2009 at 8:30 a.m. EST LEXINGTON, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that it has entered into a definitive merger agreement under which Endo Pharmaceuticals Holdings, Inc. will comm...

Bioniche Repays Revolving Credit Facility

...NC), a research-based, technology-driven Canadian biopharmaceutical company, today reported that it has received a US$20 million up-front payment from endo Pharmaceuticals per the licensing agreement related to Urocidin(TM) (announced on July 10, 2009). The Company has used a portion of this payment to re...

Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009

...CHADDS FORD, Pa., July 1 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) will announce it...stor Relations section of the website. About endo endo Pharmaceuticals is a specialty pharmaceutical comp...

HealthTronics, Inc. Commences Exchange Offer for Endocare, Inc. Shares

...d IRVINE, Calif., June 17 /PRNewswire-FirstCall/ -- HealthTronics, Inc. ("HealthTronics") (Nasdaq: HTRN ) and Endocare, Inc. ("Endocare") (Nasdaq: endo ) announced today that HealthTronics has commenced an exchange offer for all of the outstanding shares of Endocare common stock pursuant to their prev...

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

...derson during March and April and was sponsored by endo Pharmaceuticals Inc., which is developing the firs...scular disease and metabolic syndrome. ABOUT endo endo Pharmaceuticals (Nasdaq: ENDP ) is a specialty p...

Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference

...CHADDS FORD, Pa., June 5 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...o.com under the investors section. About endo endo Pharmaceuticals is a specialty pharmaceutical comp...

Endo Announces Compensation for New CFO Alan Levin

...CHADDS FORD, Pa., May 29 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...k units and an option to purchase 80,000 shares of endo common stock in connection with his appointment as...ficer. These grants are being made outside of the endo 2007 stock incentive plan but are subject to the t...

Endocare Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity

... IRVINE, Calif., May 27 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced t...

AMR Research Announces Final Agenda for Sold-Out Supply Chain Executive Conference

...Moore, President, Sisters of Mercy Health System Wesley Story, Director of Marketing Operations, Wal-Mart Dan Carbery, SVP Operations, endo Pharmaceuticals and Generics For more information about the conference, please visit: http://www.amrresearch.com/Events/Conferenc...

More>>

ENDO in Medical Technology

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...

Neurocrine Biosciences Presents Elagolix Data

...gton DC, June 10-13, 2009. The first clinical abstract presentation at endo 09 reviews the results of a Phase I study in which elagolix was evaluated o...among the placebo and elagolix groups. The second clinical abstract at endo 09 reports results from a Phase II study where the safety of elagolix was e...

Logical Therapeutics Appoints Peter A. Lankau as CEO and Director

...ny's Board of Directors. Mr. Lankau was most recently President and CEO of endo Pharmaceuticals Inc., a publicly traded specialty pharmaceutical company. ...ficant gastrointestinal risks." Mr. Lankau became President and CEO of endo Pharmaceuticals in 2005, after having served as President and COO since 200...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

...a 74 patient Phase IIb clinical trial conducted by endo Pharmaceuticals of TRANSDUR(TM)-Sufentanil, a prop...fective August 26, 2009, we will receive back from endo Pharmaceuticals the right to develop and commercialize TRANSDUR-Sufentanil in the U.S. and Canada. endo has committed to assist us in an orderly and rapid...

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...ADDS FORD, Pa., March 12 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) and its majority...evus Pharmaceuticals, a majority interest in which endo acquired earlier this year. If approved, NEBIDO i...to approximately $675 million in 2007. About endo ...

Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments

...HADDS FORD, Pa., Feb. 10 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... motor neurons. Under the terms of the agreement, endo will receive exclusive world-wide rights to the te...scovery and preclinical research activities, while endo will be responsible for all clinical development a...

Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration

...HADDS FORD, Pa., Jan. 29 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... testing and will be returned to Alexza. In 2007, endo licensed exclusive rights to develop and commercia...g from our virtual discovery program." About endo ...

Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches

... Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press relea...

Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial

... Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. In addition, AZ-002 (Staccato alprazolam) has complet...

Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients

... Phase 2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...

More>>

ENDO in Medical Products

ELVeS Endo Laser Vein System

Description: ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alternative to surgical ligation and vein stripping....
Company:biolitec, Inc.

Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)

Description: Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples....
Company:Autosuture

MULTIFIRE ENDO TA™ 30 (Single Use Loading Units with Titanium Staplers)

Description: Single Use Loading Units with Titanium Staplers for use with MULTIFIRE ENDO TA™ 30 12 mm (Single Use Staplers with Titanium Staplers)....
Company:Autosuture

MULTIFIRE ENDO TA™ 30 12 mm (Single Use Staplers with Titanium Staplers)

Description: 12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Company:Autosuture

MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)

Description: Single Use reloadable laparoscopic 12 mm linear cutting stapler for resection, transection and anastomosis with titanium staples. The stapler places two triple, staggered rows of titanium staples and simultaneously the knife divides the tissue in between. The instrument is designed for multiple ...
Company:Autosuture

MULTIFIRE ENDO SGIA™ 30 (Single Use Loading Units (SULU's) Knifeless)

Description: Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Company:Autosuture

MULTIFIRE ENDO GIA™ 60 (Single Use Loading Units (SULU's) With Titanium Staples)

Description: Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Company:Autosuture

MULTIFIRE ENDO GIA™ 30 (Single Use Loading Units (SULU's) with Titanium Staples)

Description: Single Use Loading Units (SULU's) with Titanium Staples for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Company:Autosuture

ROTICULATOR ENDO MINI-SHEARS™ 5 mm Instrument With Unipolar Cautery

Description: Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome every time....
Company:Autosuture

ROTICULATOR ENDO GRASP™ 5 mm Instrument With Spin Lock

Description: Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome every time....
Company:Autosuture

More>>

ENDO in Biological Technology

Jubilant to Work With Endo Pharmaceuticals on Drug Development

NOIDA, India, June 11 /PRNewswire/ -- - Collaboration to Provide Endo Pharmaceuticals With New Drug Candidates in Oncology Jubilant Organosys Ltd., headquartered in Noida, announced today that its Bangalore-based subsidiary, Jubilant Biosys Ltd., has entered into a discovery and ...

WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals

SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic ph...

Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America

Investor Conference Call Scheduled for December 28, 2007 at 8:30 a.m Eastern Time PALO ALTO, Calif., Dec. 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced that it has initiated a license and development partnership with E...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...HADDS FORD, Pa., July 30 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today reported f...of results of Indevus Pharmaceuticals, Inc., which endo acquired during the first quarter. Total re...IN PRODUCTS LIDODERM ((R)) : In September, endo will celebrate the tenth anniversary of the FDA ap...

Endocare and Galil Medical Announce Settlement of Litigation

... IRVINE, Calif. and YOKNEAM, Israel, July 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previous...

AEterna Zentaris Acquires All Assets from Ardana for Growth Hormone Secretagogue Compound, AEZS-130

...e interest of potential strategic partners for this project as we have already initiated partnering discussions." AEZS-130 Poster Presentation at endo The poster #P2-749 entitled, "Use of an oral GHS ghrelin-mimetic GHS as a simple diagnostic test for adult GH deficiency", G.R. Merriam, K.C.J. Y...

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

...ADDS FORD, Pa., March 30 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...aboratories. Her appointment brings the number of endo board members to nine. Roger Kimmel, chairman of the board of endo Pharmaceuticals, stated: "We are pleased to have ...

Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009

...ADDS FORD, Pa., March 16 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...evus Pharmaceuticals, Inc. (Nasdaq: IDEV ). endo has extended the subsequent offering period for al.... New York City time on Wednesday, March 18, 2009. endo and BTB do not intend to further extend the subseq...

Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period

...HADDS FORD, Pa., Feb. 23 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today announced ..., the depositary for the tender offer, has advised endo that, as of 5:00 p.m., New York City time, on Febr...tendered shares have been accepted for payment and endo will pay for all such shares promptly. ...

Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation

...estructuring includes a workforce reduction of 52 employees, representing approximately 33% of the Company's total workforce. In addition, Alexza and endo Pharmaceuticals, Inc. have agreed to mutually terminate their development agreement for AZ-003 (Staccato fentanyl), a product development candidate th...

More>>

ENDO in Biological Dictionary

Roots

...rogram in history. ... The success of Roots had lasting impact on the television industry. ... rxdentistry.com dental dentist endodontist implant endo root canal Free shipping on $75 or more. Find deals, discounts, and promotions with Roots coupons online. The Roots official AOL Music si...

Mycorrhizae

...at form between the roots of most plant ... By this mechanism, mycorrhizae increase the effective absorptive surface area of ... BioOrganics' endo and Ecto-types of mycorrhizae inoculants are noted by the USDA ... MYCORRHIZAE INOCULANTS. 2153 Vista Del Mundo. Santa Maria, CA 93458. 1-888 ... ...

Holliday structure

...NA, resolvase, ... This is a precondition for precise resolution of Holliday structures . ... The Holliday structure -resolving activity of endo VII is dissectable into three ... ... may see here the structure of a four-way Holliday -junction formed by homologous ... Eichman, The crystal ...

Endonuclease

... Endonuclease IV is a thermostable apurinic/apyrimidinic (AP) endonuclease from <em>Thermus thermophilus</em>. <em>Tth</em> endo IV will hydrolyze an AP ... NewsRx provides Endonuclease news and medical articles. ... Therefore, the endonuclease must either quickly change ...

Concatemer

...n Reaction (CCR ... process, known under the name of concatemer chain reaction (CCR) [White et al. ... site concatemer , we demonstrated that AP endo was capable of cleaving ... structure written above, while concatemer refers to double ... It is not composed of interlocked circles and may be a...

AP endonuclease

...ndonuclease IV is a thermostable apurinic/apyrimidinic ( AP ) endonuclease from <em>Thermus thermophilus</em>. <em>Tth</em> endo IV will hydrolyze an AP ... The best characterized AP endonuclease is, interestingly, the E. coli enzyme ... in vivo, but it is now clear t...

More>>